143 related articles for article (PubMed ID: 20465492)
21. MSI-low, a real phenomenon which varies in frequency among cancer types.
Halford SE; Sawyer EJ; Lambros MB; Gorman P; Macdonald ND; Talbot IC; Foulkes WD; Gillett CE; Barnes DM; Akslen LA; Lee K; Jacobs IJ; Hanby AM; Ganesan TS; Salvesen HB; Bodmer WF; Tomlinson IP; Roylance RR
J Pathol; 2003 Nov; 201(3):389-94. PubMed ID: 14595750
[TBL] [Abstract][Full Text] [Related]
22. [The Lynch syndrome].
Fracasso P; Assisi D; Stigliano V; Casale V
Clin Ter; 1999; 150(5):373-8. PubMed ID: 10687268
[TBL] [Abstract][Full Text] [Related]
23. [Genetics analysis of microsatellite instability in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families].
Smolarz B; Langner E; Romanowicz-Makowska H; Kozłowska E; Kulig A; Dziki A
Pol Merkur Lekarski; 2006 Jul; 21(121):20-3. PubMed ID: 17007286
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability testing in colorectal carcinoma: a practical guide.
Gibson J; Lacy J; Matloff E; Robert M
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):171-6.e1. PubMed ID: 24434275
[No Abstract] [Full Text] [Related]
25. High Ki-67 labeling index in human colorectal cancer with microsatellite instability.
Takagi S; Kumagai S; Kinouchi Y; Hiwatashi N; Nagashima F; Takahashi S; Shimosegawa T
Anticancer Res; 2002; 22(6A):3241-4. PubMed ID: 12530070
[TBL] [Abstract][Full Text] [Related]
26. Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndrome.
Ferreira S; Claro I; Lage P; Filipe B; Fonseca R; Sousa R; Francisco I; Chaves P; Albuquerque C; Leitão CN
Dis Colon Rectum; 2008 Jun; 51(6):909-15. PubMed ID: 18306971
[TBL] [Abstract][Full Text] [Related]
27. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
Bellizzi AM; Frankel WL
Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131
[TBL] [Abstract][Full Text] [Related]
29. [Hereditary nonpolyposis colorectal carcinoma: state of the art].
Holinski-Feder E; Morak M
Dtsch Med Wochenschr; 2008 Aug; 133(33):1690-5. PubMed ID: 18686212
[TBL] [Abstract][Full Text] [Related]
30. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
32. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
[TBL] [Abstract][Full Text] [Related]
33. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
Lynch HT; Lynch JF; Lynch PM
J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
[No Abstract] [Full Text] [Related]
34. Diagnosis of microsatellite instability-positive colorectal cancer.
Starostik P; Müller-Hermelink HK
Expert Rev Mol Diagn; 2001 May; 1(1):71-80. PubMed ID: 11901802
[TBL] [Abstract][Full Text] [Related]
35. Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative.
Landsbergen KM; Prins JB; Brunner HG; van Duijvendijk P; Nagengast FM; van Krieken JH; Ligtenberg M; Hoogerbrugge N
Fam Cancer; 2012 Jun; 11(2):259-67. PubMed ID: 22311584
[TBL] [Abstract][Full Text] [Related]
36. Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome.
Chubak B; Heald B; Sharp RR
Genet Med; 2011 Apr; 13(4):356-60. PubMed ID: 21407081
[TBL] [Abstract][Full Text] [Related]
37. [Predicted difficulties at screening of hereditary colorectal cancers including the issue of genetic testing].
Matsubara N
Nihon Rinsho; 2011 Apr; 69 Suppl 3():355-9. PubMed ID: 22213984
[No Abstract] [Full Text] [Related]
38. Informed decisions regarding microsatellite instability testing: need for an intention-to-screen analysis.
Sciallero S; Sobrero A
J Clin Oncol; 2010 Oct; 28(28):e537; author reply e538. PubMed ID: 20679625
[No Abstract] [Full Text] [Related]
39. [Microsatellite instability].
Sugai T; Uesugi N; Habano W; Suzuki K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():84-93. PubMed ID: 22213936
[No Abstract] [Full Text] [Related]
40. Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.
Drescher KM; Sharma P; Lynch HT
Clin Dev Immunol; 2010; 2010():170432. PubMed ID: 20631828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
